Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Abigail Zavod"'
Autor:
Antoine Douaihy, Sarah C. Akerman, Danesh Alam, Abigail Zavod, Narinder Nangia, Paolo Mannelli, Bernard L. Silverman, Maria A. Sullivan, Sandra D. Comer
Publikováno v:
The American Journal on Addictions
Background and objective When patients seek to discontinue buprenorphine (BUP) treatment, monthly injectable extended-release naltrexone (XR-NTX) may help them avoid relapse. The efficacy of low ascending doses of oral NTX vs placebo for patients tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed4ede4cd64eaba913087f0675dc1bb8
http://europepmc.org/articles/PMC7383475
http://europepmc.org/articles/PMC7383475
Autor:
Paolo Mannelli, Antoine B. Douaihy, Sarah C. Akerman, Anna Legedza, James Fratantonio, Abigail Zavod, Maria A. Sullivan
Publikováno v:
The American journal on addictions. 31(2)
Treatment for individuals receiving medication for opioid use disorder (MOUD) should follow an informed patient-centered approach. To better support patient autonomy in the decision-making process, clinicians should be aware of patient preferences an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4160d6ea5045b2849ac6478951e7216c
https://pubmed.ncbi.nlm.nih.gov/35137481
https://pubmed.ncbi.nlm.nih.gov/35137481
Autor:
Anna Legedza, Sarah C. Akerman, Maria A. Sullivan, Antoine Douaihy, Paolo Mannelli, Abigail Zavod
Publikováno v:
The American journal of drug and alcohol abuse. 47(6)
BACKGROUND Pharmacologic treatment is recommended for many individuals with opioid use disorder (OUD). For patients who select opioid antagonist treatment, effective management of opioid withdrawal symptoms during transition to antagonist treatment r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::970811307a0f90ed4f9557fae2414a30
https://pubmed.ncbi.nlm.nih.gov/34752714
https://pubmed.ncbi.nlm.nih.gov/34752714
Autor:
Sarah C. Akerman, Narinder Nangia, Maria Lopez-Bresnahan, Maria A. Sullivan, Thomas R. Kosten, Abigail Zavod, Efrat Aharonovich
Publikováno v:
Addictive Behaviors. 111:106538
Opioid use disorder (OUD) is associated with cognitive dysfunction. Understanding how pharmacotherapy may affect cognition is an important treatment consideration.This was a hybrid residential-outpatient, randomized trial assessing transition regimen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ec3f1eb5428b6c4789770c32f7459c8
https://doi.org/10.1016/j.addbeh.2020.106538
https://doi.org/10.1016/j.addbeh.2020.106538
Autor:
Zavod A; 1 Abigail Zavod, MD, MPH, Alkermes, Inc., Waltham, MA, USA., Akerman SC; 2 Sarah C. Akerman, MD, Alkermes, Inc., Waltham, MA, USA., Snow MM; 3 Martha M. Snow, MSN, PMHNP-BC, CARN-API, New Mexico Veterans Affairs Medical Center, Albuquerque, NM, USA., Tierney M; 4 Matt Tierney, MS, PMHNP-BC, ANP-BC, University of California San Francisco, CA, USA., Sullivan MA; 5 Maria A. Sullivan, MD, PhD, Alkermes, Inc., Waltham, MA, USA; Columbia University, New York, NY, USA.
Publikováno v:
Journal of the American Psychiatric Nurses Association [J Am Psychiatr Nurses Assoc] 2019 Jul/Aug; Vol. 25 (4), pp. 272-279. Date of Electronic Publication: 2018 Dec 20.